Hints and tips:
Related Special Reports
...He was active for years in the World Travel & Tourism Council, an industry group he helped form, and served as an honorary chair of a New York cancer hospital, Memorial Sloan Kettering....
...But it’s her work on behalf of The Frick Collection and Memorial Sloan Kettering Cancer Center (MSK) that is closest to her heart....
...This year’s event will incorporate something new, says Elizabeth Hillman, president and chief executive of the 9/11 Memorial Museum....
...He will be treated at the Memorial Sloan Kettering Cancer Center in New York....
...He will be treated at the Memorial Sloan Kettering Cancer Center in New York. He added: “During this period, the company will run normally, and I will continue to be actively engaged in managing it....
...Sloan Kettering Cancer Center....
...He had been forced to resign from his post as physician-in-chief at New York’s Memorial Sloan Kettering cancer centre because of a failure to disclose payments from healthcare companies, which the American...
...Bob Li, an oncologist at US cancer research centre Memorial Sloan Kettering, said he hoped to replicate the successful global trial for Lumykras that helped cut the approval time for the innovative cancer...
...Sloan Kettering Cancer Center in New York....
...The surgeon, from New York’s Memorial Sloan Kettering Cancer Center, likened it to “auto-vaccination”....
...Peter Bach, director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, said there was a potential trade-off that pitted the imminent need to contain the pandemic against the risk that...
...Peter Bach, director of the Center for Health Policy & Outcomes at New York’s Memorial Sloan Kettering Cancer Center, thinks that regulations such as the US Orphan Drug Act — intended to incentivise the...
...Policy and Outcomes at Memorial Sloan Kettering....
...Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering, says it helps that there are so many horses in this race....
...Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering, called for Soriot to resign....
...Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering, said Gilead had often prioritised “revenue, market share and pricing power” and so it was not a surprise that...
...Founded by two doctors at the Memorial Sloan Kettering Cancer Center, Paige launched commercially in February 2018 when it closed a $25m funding round led by Breyer Capital....
...Peter Bach, director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, said the US needed to be “vastly more explicit” about who should receive remdesivir....
...Peter Bach, director of the Center for Health Policy and Outcomes at the Memorial Sloan-Kettering cancer centre, said even if the cost of raw materials was rising, this was usually a low proportion of the...
...Sloan Kettering....
...Anna Kaltenboeck, programme director at the Center for Health Policy and Outcomes and the Drug Pricing Lab at Memorial Sloan Kettering, says the entire class of drugs known as GLP-1 receptor agonists (such...
...Mr Baselga was the physician-in-chief at Memorial Sloan Kettering Cancer Center and professor of medicine at Weill Cornell Medical College, both in New York....
...Baselga was most recently physician-in-chief at Memorial Sloan Kettering Cancer Center, but resigned from his post after an investigation found that he had failed to disclose financial ties to healthcare...
...Drug prices have only risen since the last time Sanders led a trip to buy drugs in Canada, for women with breast cancer 20 years ago....
...He has shifted his focus and now serves on the board of Memorial Sloan-Kettering Cancer Center and is chairman of the Museum of Jewish Heritage....
International Edition